The researchers compared the two treatments for all endpoints and examined regardless of whether FAAH and CNR1 gene variants (previously reported to functionally modify the genes' features) motivated the contributors' outcomes to therapy.There won't be any enough reports in women for determining infant possibility when using this medication during